Aromasin, also known by its generic name exemestane, is a medication primarily used in the treatment of hormone-receptor-positive breast cancer in postmenopausal women. It is classified as an aromatase inhibitor, which works by reducing the amount of estrogen the body produces, thus slowing the growth of cancer cells that require estrogen to grow.
For more detailed information, you can visit the following link: https://jjims.co.in/aromasin-indications-for-use/
Indications for Use
Aromasin is indicated for several specific conditions in clinical practice, including:
- Adjuvant Treatment of Early Breast Cancer: Aromasin is typically prescribed for postmenopausal women who have early-stage breast cancer and have completed two to three years of tamoxifen therapy to prevent cancer recurrence.
- Advanced Breast Cancer: It is also used in postmenopausal women with advanced hormone-receptor-positive breast cancer that has progressed following tamoxifen treatment.
- Preventive Treatment: Some studies suggest that Aromasin may have potential in reducing the risk of breast cancer in high-risk postmenopausal women, although further research is required in this area.
How Aromasin Works
Aromasin functions by specifically inhibiting the aromatase enzyme, which is responsible for converting androgens into estrogens in postmenopausal women. By lowering estrogen levels, it helps to deprive estrogen-sensitive tumors of the hormone they need to grow.
Conclusion
Aromasin has become a crucial component in the management of hormone-receptor-positive breast cancer among postmenopausal women. Its specific indications and mechanism of action make it an important option for healthcare providers when treating this type of cancer.